Consistent with previous studies, our results showed that miR-21-3p directly reduced the expression of both MAT2A and MAT2B resulting in increasing intracellular SAM contents that have been proven to impair the growth of hepatoma cells. The gene discussed is MAT2B; the disease is hepatocellular carcinoma.